Likewise, CCL2 overexpression accelerated Abeta oligomer and diffuse plaque formation and caused deficits in spatial and working memory in mouse models of AD [25, 63], while expression of a dominant negative CCL2 variant ameliorated Abeta pathology and reduced memory impairments [24]. The gene discussed is APP; the disease is Alzheimer disease.